[THE INVESTOR] Three Korean securities firms have decided to jointly acquire a pharmaceutical company’s headquarters building in the US for 350 billion won (US$301 million) as a part of their real estate investment, sources said on June 29.

Mirae Asset Daewoo, Hana Financial Investment and HMC Investment & Securities will buy the building used by Novo Nordisk, Danish pharmaceutical company, which signed a 15-year lease on the property in 2011.

Located in New Jersey, the 68,000 square-meter building is expected to generate annual return of 7 percent.

By Park Han-na (hnpark@heraldcorp.com)